The Cooper Companies, Inc. (NASDAQ:COO) Shares Acquired by Intech Investment Management LLC

Intech Investment Management LLC lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 108.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 15,560 shares of the medical device company's stock after purchasing an additional 8,091 shares during the quarter. Intech Investment Management LLC's holdings in Cooper Companies were worth $1,430,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently modified their holdings of the company. State Street Corp grew its position in Cooper Companies by 1.2% during the 3rd quarter. State Street Corp now owns 8,590,689 shares of the medical device company's stock worth $947,897,000 after purchasing an additional 104,521 shares during the period. JPMorgan Chase & Co. grew its holdings in Cooper Companies by 13.2% during the third quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company's stock worth $543,979,000 after acquiring an additional 573,908 shares during the period. Geode Capital Management LLC raised its position in Cooper Companies by 1.0% during the third quarter. Geode Capital Management LLC now owns 4,796,556 shares of the medical device company's stock valued at $527,476,000 after acquiring an additional 48,559 shares in the last quarter. Victory Capital Management Inc. lifted its holdings in Cooper Companies by 14.6% in the fourth quarter. Victory Capital Management Inc. now owns 4,525,018 shares of the medical device company's stock valued at $415,985,000 after acquiring an additional 574,899 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in Cooper Companies by 11.9% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,818,610 shares of the medical device company's stock worth $200,665,000 after purchasing an additional 194,118 shares in the last quarter. Institutional investors and hedge funds own 24.39% of the company's stock.

Remove Ads

Cooper Companies Price Performance

COO stock traded up $0.16 during trading on Wednesday, hitting $83.86. The stock had a trading volume of 1,523,398 shares, compared to its average volume of 1,291,019. The company's 50-day moving average price is $89.80 and its two-hundred day moving average price is $97.72. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The stock has a market capitalization of $16.77 billion, a P/E ratio of 43.01, a PEG ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analysts' expectations of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

COO has been the subject of several recent research reports. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Piper Sandler reaffirmed an "overweight" rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a report on Friday, March 7th. JPMorgan Chase & Co. lowered their target price on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Friday, March 7th. StockNews.com cut Cooper Companies from a "buy" rating to a "hold" rating in a research report on Wednesday, December 11th. Finally, Robert W. Baird reduced their price target on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a report on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.